Skip to main content
Equibles

Eli Casdin

Board Member

Standard Biotools Inc. (LAB)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Eli Casdin

Eli Casdin is recorded as Board Member at Standard Biotools Inc. (LAB). Earlier roles on record: Board Member at Tenaya Therapeutics, Inc. (TNYA) until December 5, 2022 and Board Member at Century Therapeutics, Inc. (IPSC) until October 1, 2022. Standard Biotools Inc. reported in an 8-K filed June 18, 2026 that Eli Casdin was appointed Class I director, effective June 17, 2026. Standard Biotools Inc. reported in an 8-K filed June 16, 2023 that Eli Casdin was appointed B-1 Director, effective June 14, 2023. Tenaya Therapeutics, Inc. reported in an 8-K filed December 7, 2022 that Eli Casdin resigned as director, effective December 5, 2022. Equibles holds 5 filed executive changes naming Eli Casdin; each is listed under recent activity with its source filing.

“The following nominees were elected to serve as Class I directors, to hold office until the Company’s 2029 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified or their earlier resignation or removal:”
Standard Biotools Inc. Form 8-K, filed June 18, 2026 · Read the filing
“The holders of Series B-1 Preferred Stock, voting separately as a class, voted all shares of Series B-1 Preferred Stock to nominate and elect Eli Casdin to the Company’s board of directors in connection with the Annual Meeting.”
Standard Biotools Inc. Form 8-K, filed June 16, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Standard Biotools Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.